Skip to Content

Caffeine / sodium benzoate Pregnancy and Breastfeeding Warnings

Caffeine / sodium benzoate Pregnancy Warnings

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used by pregnant women only if clearly needed. US FDA pregnancy category: C Comments: It is unknown whether this drug can cause fetal harm or can affect reproduction capacity. Animal reproduction studies have not been conducted.

See references

Caffeine / sodium benzoate Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation. Excreted into human milk: Yes Comments: -The average caffeine levels in the milk of 5 postpartum women given a 150 mg oral dose of this drug were 1.6, 1.5, and 0.9 mg/L at 30, 60, and 120 minutes after the dose, respectively. -The milk caffeine levels of one woman who also received a 300 mg dose were about double those after her 150 mg dose.

-Fussiness, jitteriness, and poor sleep patterns have been reported in infants of mothers with caffeine intakes equivalent to about 10 or more cups of coffee daily. -No stimulatory effects were observed in infants 3 weeks of age and older of mothers who drank 5 cups of coffee daily. -Caffeine clearance is very low in preterm and newborn infants, but reaches adult levels by 3 to 5 months of age.

See references

References for pregnancy information

  1. "Product Information. Caffeine-Sodium Benzoate (caffeine-sodium benzoate)." American Regent Laboratories Inc, Shirley, NY.

References for breastfeeding information

  1. "Product Information. Caffeine-Sodium Benzoate (caffeine-sodium benzoate)." American Regent Laboratories Inc, Shirley, NY.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.